Medicine Grand Rounds – Coccidioidomycosis

When:
October 19, 2016 @ 8:00 am – 9:00 am
2016-10-19T08:00:00-07:00
2016-10-19T09:00:00-07:00
Where:
Li Ka Shing Center for Learning and Knowledge, Berg Hall, 2nd Floor
Stanford University
300 Pasteur Drive, Stanford, CA 94304
USA
Cost:
Free
Contact:
Department of Medicine
650-721-1166
Medicine Grand Rounds - Coccidioidomycosis @ Li Ka Shing Center for Learning and Knowledge, Berg Hall, 2nd Floor | Stanford | California | United States

Presenter: David Stevens, MD
Professor of Medicine, Emeritus
Stanford University

David A. Stevens, MD is Professor of Medicine (tenured, 1978), Stanford University Medical School and Chief of the Division of Infectious Diseases and Hospital Epidemiologist, Santa Clara Valley Med. Ctr., Stanford and San Jose, California. He is President of the California Institute for Medical Research, San Jose and Principal Investigator of its Infectious Disease Research Laboratory.

He graduated from Cornell University and the Univ. of Rochester Medical School, and did internship and residencies at the Univ. of Wisconsin, Madison and the Univ. of California, Los Angeles, served at the National Cancer Inst., National Institutes of Health, Bethesda, Maryland, and was a Fellow in Infectious Diseases at Stanford. He is the author of over 600 full articles, editorials and book chapters (largely in mycology), and an approximately equal number of abstracts, and has served on the editorial boards of several journals.

He was the 1999 recipient of the Rhoda Benham Medal from the Medical Mycology Society of the Americas, the 2006 recipient in Paris of the Lucille Georg Medal from the International Society for Human and Animal Mycology, and the 2006 recipient of the Charles E. Smith Memorial Award from the Coccidioidomycosis Study Group. A newly discovered bacterium has been named in his honor (Halomonas stevensii), in recognition of his contributions to the discovery of new species in this genus. He was Project Leader of the Opportunistic Mycoses Section, and then the Aspergillosis Section, of the NIAID Mycoses Study Group (National Institutes of Health multicenter clinical trials group) 1990-2000. He was Chair of the committee writing the first Practice Guidelines on Aspergillosis for the Infectious Diseases Society of America, and has later served on this committee as well as the committee writing the Practice Guidelines on Coccidioidomycosis.

He has delivered 6 endowed, “named”, or keynote lectureships on 3 continents, and was voted by his peers to “Best Doctors in America”, “Best Doctors”, “America’s Top Doctors”, “Guide to America’s Top Physicians” and “Top Doctor, The Leading Physicians of the World”, and to Chair, Mycology Div., American Society for Microbiology. Eight of his former trainees are full professors in the full-time faculty of medical schools, and others are at other ranks of the professoriate, clinical faculty, hospital chiefs of infectious diseases, directors of clinical microbiology laboratories, full-time laboratory researchers at national laboratories or research institutes, or clinicians. Three of his former Fellows have also been elected Chairs of the Mycology Div., Amer. Soc. for Microbiol.. He is a member (emeritus) of the American Society for Clinical Investigation and has been elected to 3 Fellowships: the American College of Physicians, the Infectious Diseases Society of America, and the American Academy of Microbiology. He is a Co-Organizer of the biennial Advances Against Aspergillosis international meetings.